[1]
A. Kumar and A. S. Prakash, “Effectiveness and Safety of Hydroxychloroquine compared to Teneligliptin in uncontrolled T2DM patients as add-on therapy”, J ASEAN Fed Endocr Soc, vol. 34, no. 1, p. 87, Jul. 2019.